Regulations Amending the Precursor Control Regulations (Emerging Fentanyl Precursors): SOR/2024-100

Canada Gazette, Part II, Volume 158, Number 12

Registration
SOR/2024-100 May 27, 2024

CONTROLLED DRUGS AND SUBSTANCES ACT

P.C. 2024-576 May 24, 2024

Her Excellency the Governor General in Council, on the recommendation of the Minister of Mental Health and Addictions and Associate Minister of Health, makes the annexed Regulations Amending the Precursor Control Regulations (Emerging Fentanyl Precursors) under subsection 55(1)footnote a of the Controlled Drugs and Substances Act footnote b.

Regulations Amending the Precursor Control Regulations (Emerging Fentanyl Precursors)

Amendment

1 The portion of item 28 of the schedule to the Precursor Control Regulations footnote 1 in column 1 is replaced by the following:
Item

Column 1

Precursor set out in Part 1 of Schedule VI to the Act
28 4-Piperidone (piperidin-4-one), its salts, derivatives and analogues and salts of derivatives and analogues, including:
  • (1) 1-boc-4-piperidone (tert-butyl 4-oxopiperidine-1-carboxylate)
  • (2) 3-methyl-4-piperidone (3-methylpiperidin-4-one)
  • (3) 1-benzyl-4-piperidone (1-benzylpiperidin-4-one)

Coming into Force

2 These Regulations come into force on the 90th day after the day on which they are published in the Canada Gazette, Part II.

N.B. The Regulatory Impact Analysis Statement for these Regulations appears following SOR/2024-98, Order Amending Schedules I and VI to the Controlled Drugs and Substances Act (Synthetic Opioids and Emerging Fentanyl Precursors).